|
|
|
|
|
05.11.25 - 00:00
|
Corteva, Inc. Q3 Loss Decreases, Beats Estimates (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Corteva, Inc. (CTVA) revealed Loss for third quarter that Decreased from the same period last year and beat the Street estimates.The company's bottom line totaled -$320 mill......
|
|
|
|
|
|
|
|
|
|
|
|
|
31.10.25 - 13:09
|
Corteva Declares Quarterly Dividend (PR Newswire)
|
|
|
INDIANAPOLIS, Oct. 31, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable December 15, 2025, to the Company's shareholders of record on December 1, 2025. EIDP, Inc. Announces......
|
|
|
|
|
|
|
|
|
14.10.25 - 13:21
|
Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and Corteva (Business Wire)
|
|
|
Investment drives launch of Phytalix®, a new broad spectrum biofungicide delivering practical, sustainable disease control for farmers globallyITHACA, N.Y.--(BUSINESS WIRE)--Ascribe Bio (“Ascribe”), an innovator in natural crop protection, today announced the closing of an oversubscribed $12 million Series A financing round, co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. The financing also included participation from new and existing investors including Syngenta Group Ventures, Trailhead Capital, Silver Blue LLC, Cultivation Capital, and The Yield Lab.
This milestone advances Ascribe's small-molecule technology platform and supports the upcoming commercial launch of Phytalix®. Phytalix is a revolutionary 'biofungicide without compromise' that provides the health and sustainability benefits of biologicals with the ease of use and affordability of traditional chemical crop protection products.
“Ascribe's approach to biological solutions provides farmers with...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
